Summary

A registry and a follow-up of patients using the LifeVest Wearable Cardiac Defibrillator (WCD), WEARIT-II, shows that the vest saves lives and can be safely used to bridge a decision for appropriate implantable cardioverter defibrillator therapy. The purpose of the study was to provide prospective data on the safety and efficacy of a bridging strategy with the WCD in a real-world setting. This article presents 18-month results for the first 882 patients enrolled in the United States from August 2011 through April 2013.